The Effect of Vascular Endothelial Growth Factor Antagonist Peptide (VGB4) on Breast Tumor Growth Suppression in Vivo

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

FARZANEH BEHELGARDI M.; ZAHRI S.; MASHAYEKHI F.; ASGHARI S.M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Armaghane Danesh Year:2019 | Volume:23 | Issue:6 (131) Page(s): 683-693

Download Full-Text

Persian Verion

View:

649

Download:

Cites:

Information Journal Paper

Title

The Effect of Vascular Endothelial Growth Factor Antagonist Peptide (VGB4) on Breast Tumor Growth Suppression in Vivo

Author(s)

FARZANEH BEHELGARDI M. | ZAHRI S. | MASHAYEKHI F. | ASGHARI S.M. | Issue Writer Certificate

Keywords

AngiogenesisQ2

PeptideQ1

Vascular Endothelial Growth FactorQ1

Breast CancerQ2

Abstract

Background & aim: The Vascular Endothelial Growth Factor of the tumor, which binds to its receptors at the level of endothelial cells, plays an important role in vascular permeability and tumor Angiogenesis. In the present study, a vascular endothelial cell growth factor antagonist Peptide (VEGF) was designed with the goal of inhibiting the desired Peptide (VGB4) interfering with endothelial growth factor receptors in its receptors, thereby inhibiting the signaling pathways Angiogenesis. Methods: In the present experimental study, 42 female Balb / C mice (4 to 6 weeks old) with an average weight of 20 grams were used. Tissue cell line 4T1 was used to model Breast Cancer. It turned out after subcutaneous transplantation of mammary tumors in animals, daily intraperitoneal injection of different doses of VGB4 Peptide (10, 5, 2. 5, 1, 0. 25 mg / kg) for 14 days, and the antitumor potential of different Peptide concentrations during the injection period compared to the control was statistically analyzed. Data were analyzed by ANOVA and Duncan tests. Results: Increasing the doses of Peptide reduced the tumor growth in treated groups, but no significant inhibitory effect was seen on tumor growth by increasing the dose from 5 mg / kg to 10 mg / kg. Therefore, the dose of 5 mg / kg is the best anti-tumor dose of the VGB4 Peptide. Conclusion: VGB4 Peptide had a significant inhibitory effect on the growth of Breast Cancer carcinoma of the 4T1 cell line. Due to the effects of VIT4 antitumor, it may be possible to use this Peptide for cancer treatment in the future.

Cites

No record.

References

No record.

Cite

APA: Copy

FARZANEH BEHELGARDI, M., ZAHRI, S., MASHAYEKHI, F., & ASGHARI, S.M.. (2019). The Effect of Vascular Endothelial Growth Factor Antagonist Peptide (VGB4) on Breast Tumor Growth Suppression in Vivo. ARMAGHAN DANESH, 23(6 (131) ), 683-693. SID. https://sid.ir/paper/77498/en

Vancouver: Copy

FARZANEH BEHELGARDI M., ZAHRI S., MASHAYEKHI F., ASGHARI S.M.. The Effect of Vascular Endothelial Growth Factor Antagonist Peptide (VGB4) on Breast Tumor Growth Suppression in Vivo. ARMAGHAN DANESH[Internet]. 2019;23(6 (131) ):683-693. Available from: https://sid.ir/paper/77498/en

IEEE: Copy

M. FARZANEH BEHELGARDI, S. ZAHRI, F. MASHAYEKHI, and S.M. ASGHARI, “The Effect of Vascular Endothelial Growth Factor Antagonist Peptide (VGB4) on Breast Tumor Growth Suppression in Vivo,” ARMAGHAN DANESH, vol. 23, no. 6 (131) , pp. 683–693, 2019, [Online]. Available: https://sid.ir/paper/77498/en

Related Journal Papers